Skip to Content

Aroa Biosurgery Ltd Ordinary Shares ARX

Morningstar Rating
A$0.62 −0.01 (1.59%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ARX is trading at a 543% premium.
Price
A$0.62
Fair Value
A$8.16
Uncertainty
Very High
1-Star Price
A$5.47
5-Star Price
A$8.69
Economic Moat
Mgk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ARX is a good fit for your portfolio.

Trading Information

Previous Close Price
A$0.63
Day Range
A$0.620.63
52-Week Range
A$0.481.00
Bid/Ask
A$0.62 / A$0.63
Market Cap
A$213.41 Mil
Volume/Avg
87,802 / 331,862

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.39
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees

Comparables

Valuation

Metric
ARX
603301
MMSI
Price/Earnings (Normalized)
20.2825.70
Price/Book Value
2.500.983.78
Price/Sales
3.391.423.68
Price/Cash Flow
7.8820.67
Price/Earnings
ARX
603301
MMSI

Financial Strength

Metric
ARX
603301
MMSI
Quick Ratio
5.571.774.22
Current Ratio
7.832.466.03
Interest Coverage
3.936.17
Quick Ratio
ARX
603301
MMSI

Profitability

Metric
ARX
603301
MMSI
Return on Assets (Normalized)
1.57%9.17%
Return on Equity (Normalized)
2.23%15.14%
Return on Invested Capital (Normalized)
1.68%10.93%
Return on Assets
ARX
603301
MMSI
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
NfdhhpkpnYbkssbz$180.0 Bil
Stryker Corp
SYK
MwdghgnrqcXdjyn$131.3 Bil
Boston Scientific Corp
BSX
NqnyqgfbjJmzvt$112.0 Bil
Medtronic PLC
MDT
NglqfgknMhmycg$104.8 Bil
Edwards Lifesciences Corp
EW
HrvthklpFjqdns$52.3 Bil
DexCom Inc
DXCM
TlfmsznxYrrqw$46.1 Bil
Koninklijke Philips NV ADR
PHG
KzbdjjcsWwsvlzs$23.9 Bil
Zimmer Biomet Holdings Inc
ZBH
BhjflfvhdWrrgj$22.0 Bil
Steris PLC
STE
LmpwkzrlqXbxkkcf$21.4 Bil
Align Technology Inc
ALGN
FhwvxgknVxkjqlp$18.5 Bil

Sponsor Center